EyePoint Pharmaceuticals
EYPT
#5711
Rank
HK$8.62 B
Marketcap
HK$103.32
Share price
-5.92%
Change (1 day)
94.65%
Change (1 year)

Earnings for EyePoint Pharmaceuticals (EYPT)

Earnings in 2025 (TTM): -HK$1.68 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company's current earnings are HK$42.34 Million. In 2024 the company made an earning of -HK$1.12 Billion a decrease over its 2023 earnings that were of -HK$0.55 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for EyePoint Pharmaceuticals from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$1.68 Billion50.5%
2024 -HK$1.12 Billion104.29%
2023 -HK$0.55 Billion-29.88%
2022 -HK$0.78 Billion87.2%
2021 -HK$0.42 Billion38.58%
2020 -HK$0.3 Billion-24.56%
2019 -HK$0.4 Billion
2017 -HK$0.19 Billion22.59%
2016 -HK$0.15 Billion-8.02%
2015 -HK$0.17 Billion-296.09%
2014 HK$81.72 M-174.02%
2013 -HK$0.12 Billion37.42%
2012 -HK$80.34 Million-56.29%
2011 -HK$0.19 Billion-1062.38%
2010 HK$19.09 M-250.43%
2009 -HK$12.7 Million-89.5%
2008 -HK$0.13 Billion
2005 -HK$74.59 Million56.99%
2004 -HK$47.51 Million73.7%
2003 -HK$27.36 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-HK$16.92 Million-98.99% Bahamas
NRC Health
NRC
HK$0.21 B-112.86%๐Ÿ‡บ๐Ÿ‡ธ USA